down arrow

Indoco Remedies

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE873D01024
  • NSEID: INDOCO
  • BSEID: 532612
INR
232.20
6.7 (2.97%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 17.39 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Divi's Lab.
Bajaj Healthcare
Cipla
Windlas Biotech
Sun Pharma.Inds.
Torrent Pharma
Novartis India
Solara Active
Mankind Pharma
Indoco Remedies
Beta Drugs Ltd
Why is Indoco Remedies Ltd ?
1
Poor long term growth as Operating profit has grown by an annual rate -4.03% of over the last 5 years
2
With a fall in PBT of -314.48%, the company declared Very Negative results in Dec 24
  • The company has declared negative results for the last 9 consecutive quarters
  • OPERATING PROFIT TO INTEREST(Q) Lowest at 0.75 times
  • INTEREST(HY) At Rs 33.94 cr has Grown at 28.76%
  • ROCE(HY) Lowest at 5.22 %
3
Stock is technically in a Bearish range
  • The technical trend has deteriorated from Mildly Bearish on 07-Apr-25 and has generated -2.65% returns since then
  • Multiple factors for the stock are Bearish like MACD, Bollinger Band and KST
4
Consistent Underperformance against the benchmark over the last 3 years
  • Along with generating -35.33% returns in the last 1 year, the stock has also underperformed BSE 500 in each of the last 3 annual periods
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Drugs)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Indoco Remedies for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Indoco Remedies
-34.03%
-0.84
41.86%
SENSEX
0.45%
0.03
14.48%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
9.79%
EBIT Growth (5y)
-4.03%
EBIT to Interest (avg)
7.37
Debt to EBITDA (avg)
1.70
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.18
Tax Ratio
100.00%
Dividend Payout Ratio
14.04%
Pledged Shares
0
Institutional Holding
20.15%
ROCE (avg)
13.47%
ROE (avg)
10.65%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
33
Price to Book Value
1.91
EV to EBIT
76.35
EV to EBITDA
19.29
EV to Capital Employed
1.53
EV to Sales
1.67
PEG Ratio
NA
Dividend Yield
0.66%
ROCE (Latest)
4.93%
ROE (Latest)
2.25%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

0What is working for the Company
Icon
NO KEY POSITIVE TRIGGERS
-29What is not working for the Company
OPERATING PROFIT TO INTEREST(Q)

Lowest at 0.75 times

INTEREST(HY)

At Rs 33.94 cr has Grown at 28.76%

ROCE(HY)

Lowest at 5.22 %

DEBT-EQUITY RATIO(HY)

Highest at 0.77 times

PBDIT(Q)

Lowest at Rs 12.03 cr.

PBT LESS OI(Q)

Lowest at Rs -32.80 cr.

PAT(Q)

Lowest at Rs -27.38 cr.

NET SALES(Q)

Lowest at Rs 410.55 cr

OPERATING PROFIT TO NET SALES (Q)

Lowest at 2.93%

EPS(Q)

Lowest at Rs -2.86

Loading Valuation Snapshot...
Here's what is not working for Indoco Remedies
Operating Profit to Interest - Quarterly
Lowest at 0.75 times and Fallen
each quarter in the last five quarters
MOJO Watch
The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Profit Before Tax less Other Income (PBT) - Quarterly
At Rs -32.80 cr has Fallen at -439.8 %
over average PBT of the previous four quarters of Rs 9.65 Cr
MOJO Watch
Near term PBT trend is very negative

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
At Rs -27.38 cr has Fallen at -546.9 %
over average PAT of the previous four quarters of Rs 6.13 Cr
MOJO Watch
Near term PAT trend is very negative

PAT (Rs Cr)

Operating Profit (PBDIT) - Quarterly
Lowest at Rs 12.03 cr. and Fallen
each quarter in the last five quarters
MOJO Watch
Near term Operating Profit trend is quite negative

Operating Profit (Rs Cr)

Profit Before Tax less Other Income (PBT) - Quarterly
Lowest at Rs -32.80 cr. and Fallen
each quarter in the last five quarters
MOJO Watch
Near term PBT trend is very negative

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
Lowest at Rs -27.38 cr. and Fallen
each quarter in the last five quarters
MOJO Watch
Near term PAT trend is very negative

PAT (Rs Cr)

Interest - Half Yearly
At Rs 33.94 cr has Grown at 28.76%
over previous Half yearly period
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (Rs cr)

Debt-Equity Ratio - Half Yearly
Highest at 0.77 times and Grown
each half year in the last five half yearly periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Net Sales - Quarterly
Lowest at Rs 410.55 cr
in the last five quarters
MOJO Watch
Near term sales trend is negative

Net Sales (Rs Cr)

Net Sales - Quarterly
At Rs 410.55 cr has Fallen at -7.4 %
over average Net Sales of the previous four quarters of Rs 443.30 Cr
MOJO Watch
Near term sales trend is negative

Net Sales (Rs Cr)

Operating Profit Margin - Quarterly
Lowest at 2.93%
in the last five quarters
MOJO Watch
Company's efficiency has deteriorated

Operating Profit to Sales

Earnings per Share (EPS) - Quarterly
Lowest at Rs -2.86
in the last five quarters
MOJO Watch
Declining profitability; company has created lower earnings for shareholders

EPS (Rs)